Tcr2 Therapeutics Correlations
| TCRRDelisted Stock | USD 1.48 0.00 0.00% |
The current 90-days correlation between Tcr2 Therapeutics and Agenus Inc is -0.05 (i.e., Good diversification). The correlation of Tcr2 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Tcr2 Therapeutics Correlation With Market
Very good diversification
The correlation between Tcr2 Therapeutics and DJI is -0.31 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Tcr2 |
Moving together with Tcr2 Stock
Moving against Tcr2 Stock
| 0.86 | JNJ | Johnson Johnson | PairCorr |
| 0.79 | PTAIF | PT Astra International | PairCorr |
| 0.79 | PTITF | PT Indosat Tbk Earnings Call This Week | PairCorr |
| 0.78 | XOM | Exxon Mobil Corp Earnings Call Today | PairCorr |
| 0.75 | TRV | The Travelers Companies | PairCorr |
| 0.74 | HPQ | HP Inc | PairCorr |
| 0.7 | VZ | Verizon Communications | PairCorr |
| 0.69 | INTC | Intel | PairCorr |
| 0.68 | KO | Coca Cola Earnings Call This Week | PairCorr |
| 0.67 | PTAIY | Astra International Tbk | PairCorr |
| 0.67 | CAT | Caterpillar Earnings Call This Week | PairCorr |
| 0.63 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.59 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.47 | MCD | McDonalds Earnings Call This Week | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tcr2 Stock performing well and Tcr2 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tcr2 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AFMD | 3.76 | (1.86) | 0.00 | (0.68) | 0.00 | 7.28 | 43.61 | |||
| PIRS | 1.68 | (0.32) | 0.00 | (5.74) | 0.00 | 3.23 | 10.25 | |||
| ADCT | 5.68 | (0.28) | 0.00 | 0.94 | 0.00 | 8.41 | 99.23 | |||
| AGEN | 4.25 | (0.30) | 0.00 | (0.12) | 0.00 | 10.48 | 25.24 | |||
| RVMD | 1.93 | (0.16) | 0.00 | (0.20) | 0.00 | 4.70 | 16.40 | |||
| BDTX | 3.44 | (0.30) | 0.00 | (0.14) | 0.00 | 5.47 | 25.91 | |||
| BCEL | 3.90 | 0.13 | 0.02 | 0.26 | 5.00 | 7.53 | 23.80 | |||
| PASG | 6.88 | 0.46 | 0.04 | (1.44) | 6.85 | 20.97 | 84.39 | |||
| HARP | 3.55 | 0.59 | 0.12 | (1.37) | 3.28 | 9.59 | 22.48 | |||
| ALEC | 4.30 | (1.38) | 0.00 | (0.88) | 0.00 | 6.94 | 42.73 |
Tcr2 Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tcr2 Therapeutics stock to make a market-neutral strategy. Peer analysis of Tcr2 Therapeutics could also be used in its relative valuation, which is a method of valuing Tcr2 Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Tcr2 Therapeutics Corporate Management
| Angela Justice | Chief Officer | Profile | |
| Patrick Baeuerle | Founder Board | Profile | |
| Richard Roomberg | VP Controller | Profile | |
| Dr MBA | CEO Pres | Profile | |
| Margaret JD | Head Sec | Profile | |
| Rosemary Harrison | Chief Officer | Profile | |
| Peter Olagunju | Chief Officer | Profile |
Still Interested in Tcr2 Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.